PAGA: Protective antigen
Protein in Bacillus anthracis that 5 drugs act on.
- Drugs that act on it: 5
- Approved: 3
- In phases 1 to 3: 2
- Sponsors: 4
Who is on it, and how far along
Every drug ChEMBL records acting on PAGA, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Antibody 2
- Other 3
Approved3
Phase 30
Phase 20
Phase 12
Sponsors
Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.
- Elusys Therapeutics120%
- Emergent BioSolutions120%
- GSK120%
- PharmAthene, Inc.120%
| RaxibacumabBoxed warning | Approved | GSK | Antibody | Binding agentProtective antigen binding agent | 2 |
| Bacillus anthracis protective antigen, adsorbed | Approved | — | Other | Vaccine antigenProtective antigen vaccine antigen | 0 |
| ObiltoxaximabBoxed warning | Approved | Elusys Therapeutics | Antibody | Binding agentProtective antigen binding agent | 0 |
| AVP-21D9 | Phase 1 | Emergent BioSolutions | Other | InhibitorProtective antigen inhibitor | 0 |
| MDX-1303 | Phase 1 | PharmAthene, Inc. | Other | InhibitorProtective antigen inhibitor | 0 |
| Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax | Raxibacumab | — | Not yet recruiting | Emergent BioSolutions | Mar 17, 2026 |
| Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario | Raxibacumab | Phase 4 | Not yet recruiting | Emergent BioSolutions | Jun 30, 2014 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL5352, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets